A Hollywood plaintiff is the name plaintiff in a proposed class action lawsuit alleging Boehringer Ingelheim Pharmaceutical Inc. shorted consumers using its Combivent Respimat asthma inhaler.

The 24-page federal lawsuit in Connecticut accuses the German company of conducting “an extensive, widespread, comprehensive and uniform nationwide marketing campaign” that misrepresented the dosage of its Combivent inhalers. It claims the company offered metered-dose inhalers with a set number of puffs, but the product fell far short.